-
1
-
-
77957656300
-
A practical approach to monitoring patients on biological agents for the treatment of psoriasis
-
Emer JJ, Frankel A, Zeichner JA,. A practical approach to monitoring patients on biological agents for the treatment of psoriasis. J Clin Aesthet Dermatol 2010; 3: 20-6.
-
(2010)
J Clin Aesthet Dermatol
, vol.3
, pp. 20-26
-
-
Emer, J.J.1
Frankel, A.2
Zeichner, J.A.3
-
2
-
-
43249114046
-
To test or not to test? An evidence-based assessment of the value of screening and monitoring tests when using systemic biologic agents to treat psoriasis
-
Huang W, Cordoro KM, Taylor SL, et al. To test or not to test? An evidence-based assessment of the value of screening and monitoring tests when using systemic biologic agents to treat psoriasis. J Am Acad Dermatol 2008; 58: 970-7.
-
(2008)
J Am Acad Dermatol
, vol.58
, pp. 970-977
-
-
Huang, W.1
Cordoro, K.M.2
Taylor, S.L.3
-
3
-
-
37349054996
-
From the Medical Board of the National Psoriasis Foundation: Monitoring and vaccinations in patients treated with biologics for psoriasis
-
DOI 10.1016/j.jaad.2007.08.030, PII S0190962207013151
-
Lebwohl M, Bagel J, Gelfand JM, et al. From the Medical Board of the National Psoriasis Foundation: monitoring and vaccinations in patients treated with biologics for psoriasis. J Am Acad Dermatol 2008; 58: 94-105. (Pubitemid 350302037)
-
(2008)
Journal of the American Academy of Dermatology
, vol.58
, Issue.1
, pp. 94-105
-
-
Lebwohl, M.1
Bagel, J.2
Gelfand, J.M.3
Gladman, D.4
Gordon, K.B.5
Hsu, S.6
Kalb, R.E.7
Kimball, A.B.8
Korman, N.J.9
Krueger, G.G.10
Mease, P.11
Morison, W.L.12
Paller, A.13
Pariser, D.M.14
Ritchlin, C.15
Strober, B.16
Van Voorhees, A.17
Weinstein, G.D.18
Young, M.19
Horn, L.20
more..
-
4
-
-
77951594760
-
The treatment of moderate-to-severe psoriasis: Prescreening and monitoring psoriatic patients on biologics
-
Levine D, Strober BE,. The treatment of moderate-to-severe psoriasis: prescreening and monitoring psoriatic patients on biologics. Semin Cutan Med Surg 2010; 29: 28-34.
-
(2010)
Semin Cutan Med Surg
, vol.29
, pp. 28-34
-
-
Levine, D.1
Strober, B.E.2
-
5
-
-
41949094481
-
Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics
-
DOI 10.1016/j.jaad.2008.02.039, PII S0190962208002739
-
Menter A, Gottlieb A, Feldman SR, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol 2008; 58: 826-50. (Pubitemid 351509656)
-
(2008)
Journal of the American Academy of Dermatology
, vol.58
, Issue.5
, pp. 826-850
-
-
Menter, A.1
Gottlieb, A.2
Feldman, S.R.3
Van Voorhees, A.S.4
Leonardi, C.L.5
Gordon, K.B.6
Lebwohl, M.7
Koo, J.Y.M.8
Elmets, C.A.9
Korman, N.J.10
Beutner, K.R.11
Bhushan, R.12
-
6
-
-
49849097373
-
Monitoring biologics for the treatment of psoriasis
-
Papp KA,. Monitoring biologics for the treatment of psoriasis. Clin Dermatol 2008; 26: 515-21.
-
(2008)
Clin Dermatol
, vol.26
, pp. 515-521
-
-
Papp, K.A.1
-
7
-
-
70249137988
-
European S3-guidelines on the systemic treatment of psoriasis vulgaris
-
Pathirana D, Ormerod AD, Saiag P, et al. European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol 2009; 23 (Suppl. 2): 1-70.
-
(2009)
J Eur Acad Dermatol Venereol
, vol.23
, Issue.SUPPL. 2
, pp. 1-70
-
-
Pathirana, D.1
Ormerod, A.D.2
Saiag, P.3
-
8
-
-
71949087471
-
British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009
-
Smith CH, Anstey AV, Barker JN, et al. British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009. Br J Dermatol 2009; 161: 987-1019.
-
(2009)
Br J Dermatol
, vol.161
, pp. 987-1019
-
-
Smith, C.H.1
Anstey, A.V.2
Barker, J.N.3
-
9
-
-
0018099294
-
Severe psoriasis - oral therapy with a new retinoid
-
Fredriksson T, Pettersson U,. Severe psoriasis-oral therapy with a new retinoid. Dermatologica 1978; 157: 238-44. (Pubitemid 8387357)
-
(1978)
Dermatologica
, vol.157
, Issue.4
, pp. 238-244
-
-
Fredriksson, T.1
Pettersson, U.2
-
10
-
-
84871774938
-
-
National Cancer Institute Published June 14, 2010. Available at: (last accessed 4 May 2011)
-
National Cancer Institute. Common Terminology Criteria for Adverse Events-version 4.03. Published June 14, 2010. Available at: (last accessed 4 May 2011).
-
Common Terminology Criteria for Adverse Events - Version 4.03
-
-
-
11
-
-
77953097470
-
Neutropenia in patients receiving anti-tumor necrosis factor therapy
-
Hastings R, Ding T, Butt S, et al. Neutropenia in patients receiving anti-tumor necrosis factor therapy. Arthritis Care Res (Hoboken) 2010; 62: 764-9.
-
(2010)
Arthritis Care Res (Hoboken)
, vol.62
, pp. 764-769
-
-
Hastings, R.1
Ding, T.2
Butt, S.3
-
14
-
-
77956049370
-
Risk of elevated liver enzymes associated with TNF inhibitor utilisation in patients with rheumatoid arthritis
-
Sokolove J, Strand V, Greenberg JD, et al. Risk of elevated liver enzymes associated with TNF inhibitor utilisation in patients with rheumatoid arthritis. Ann Rheum Dis 2010; 69: 1612-17.
-
(2010)
Ann Rheum Dis
, vol.69
, pp. 1612-1617
-
-
Sokolove, J.1
Strand, V.2
Greenberg, J.D.3
-
15
-
-
77953197048
-
C-reactive protein and leucocyte activation in psoriasis vulgaris according to severity and therapy
-
Coimbra S, Oliveira H, Reis F, et al. C-reactive protein and leucocyte activation in psoriasis vulgaris according to severity and therapy. J Eur Acad Dermatol Venereol 2010; 24: 789-96.
-
(2010)
J Eur Acad Dermatol Venereol
, vol.24
, pp. 789-796
-
-
Coimbra, S.1
Oliveira, H.2
Reis, F.3
-
16
-
-
47549084413
-
Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis
-
DOI 10.1111/j.1365-2133.2008.08628.x
-
Strober B, Teller C, Yamauchi P, et al. Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis. Br J Dermatol 2008; 159: 322-30. (Pubitemid 352009830)
-
(2008)
British Journal of Dermatology
, vol.159
, Issue.2
, pp. 322-330
-
-
Strober, B.1
Teller, C.2
Yamauchi, P.3
Miller, J.L.4
Hooper, M.5
Yang, Y.-C.6
Dann, F.7
-
17
-
-
11344279659
-
C-reactive protein levels and outcomes after statin therapy
-
DOI 10.1056/NEJMoa042378
-
Ridker PM, Cannon CP, Morrow D, et al. C-reactive protein levels and outcomes after statin therapy. N Engl J Med 2005; 352: 20-8. (Pubitemid 40075677)
-
(2005)
New England Journal of Medicine
, vol.352
, Issue.1
, pp. 20-28
-
-
Ridker, P.M.1
Cannon, C.P.2
Morrow, D.3
Rifai, N.4
Rose, L.M.5
McCabe, C.H.6
Pfeffer, M.A.7
Braunwald, E.8
-
18
-
-
77949797498
-
Antinuclear antibodies associate with loss of response to antitumour necrosis factor-alpha therapy in psoriasis: A retrospective, observational study
-
Pink AE, Fonia A, Allen MH, et al. Antinuclear antibodies associate with loss of response to antitumour necrosis factor-alpha therapy in psoriasis: a retrospective, observational study. Br J Dermatol 2010; 162: 780-5.
-
(2010)
Br J Dermatol
, vol.162
, pp. 780-785
-
-
Pink, A.E.1
Fonia, A.2
Allen, M.H.3
|